N-acetyl Cysteine Reverses Bio-behavioural Changes Induced by Prenatal Inflammation, Adolescent Methamphetamine Exposure and Combined Challenges
Overview
Affiliations
Rationale: Schizophrenia is associated with prenatal inflammation and/or postnatal stressors such as drug abuse, resulting in immune-redox dysfunction. Antioxidants may offer therapeutic benefits.
Objectives: The objective of this study is to investigate N-acetyl cysteine (NAC) as a therapeutic antioxidant to reverse schizophrenia-like bio-behavioural changes in rats exposed to maternal immune activation (MIA), adolescent methamphetamine (MA) or a combination thereof.
Methods: Sprague-Dawley offspring prenatally exposed to saline/lipopolysaccharide (LPS) received saline or MA (0.2-6 mg kg twice daily × 16 days) during adolescence and divided into LPS, MA and LPS + MA groups. Vehicle/NAC (150 mg kg × 14 days) was administered following MA/saline exposure on postnatal day 51-64. Social interaction, novel object recognition and prepulse inhibition (PPI) of startle, as well as regional brain monoamines, lipid peroxidation, plasma reactive oxygen species (ROS) and pro- and anti-inflammatory cytokines (TNF-α; IL-10), were assessed.
Results: NAC reversed LPS, MA and LPS + MA-induced anxiety-like social withdrawal behaviours, as well as MA and LPS + MA-induced deficits in recognition memory. PPI deficits were evident in MA, LPS and LPS + MA models, with NAC reversing that following LPS + MA. NAC reversed LPS, MA and LPS + MA-induced frontal cortical dopamine (DA) and noradrenaline (NA) elevations, LPS and LPS + MA-induced frontal cortical 3,4-dihydroxyphenylacetic acid (DOPAC), serotonin (5-HT) and striatal NA deficits as well as LPS + MA-induced frontal cortical 5-HT turnover. Decreased IL-10 in the LPS, MA and LPS + MA animals, and increased TNF-α in the LPS and MA animals, was reversed with NAC. NAC also reversed elevated lipid peroxidation and ROS in the LPS and LPS + MA animals.
Conclusions: Prenatal LPS, LPS + postnatal MA challenge during adolescence, and to a lesser extent MA alone, promotes schizophrenia-like bio-behavioural changes later in life that are reversed by NAC, emphasizing therapeutic potential for schizophrenia and MA-associated psychosis. The nature and timing of the dual-hit are critical.
Kawikova I, Hakenova K, Lebedeva M, Kleteckova L, Jakob L, Spicka V Physiol Res. 2024; 73(S2):S615-S639.
PMID: 39589306 PMC: 11627263.
Prenatal environmental risk factors for autism spectrum disorder and their potential mechanisms.
Love C, Sominsky L, OHely M, Berk M, Vuillermin P, Dawson S BMC Med. 2024; 22(1):393.
PMID: 39278907 PMC: 11404034. DOI: 10.1186/s12916-024-03617-3.
Romero-Miguel D, Casquero-Veiga M, Lamanna-Rama N, Torres-Sanchez S, MacDowell K, Garcia-Partida J Transl Psychiatry. 2024; 14(1):14.
PMID: 38191622 PMC: 10774365. DOI: 10.1038/s41398-023-02652-7.
Adraoui F, Douw L, Martens G, Maas D Int J Mol Sci. 2023; 24(9).
PMID: 37175387 PMC: 10177877. DOI: 10.3390/ijms24097680.
De Simone G, Mazza B, Vellucci L, Barone A, Ciccarelli M, de Bartolomeis A Antioxidants (Basel). 2023; 12(4).
PMID: 37107350 PMC: 10135787. DOI: 10.3390/antiox12040975.